Direct Biologics
exit covid phase trial results continued | Direct Biologics
Company
Deck Type
Deck date
October 2022
Slide
22 of 36
Related slides by other companies
Oculis
Results
August 2023
consistent results with in optimize trials | Oculis
Matson
Results
January 2024
preliminary fourth quarter results continued | Matson
Ocuphire Pharma
Results
June 2021
of subjects letter gain in near letter loss in distance | Ocuphire Pharma
Ocuphire Pharma
Results
March 2022
mean pupil diameter over time by mydriatic agents | Ocuphire Pharma
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights